In recent studies, several STING inhibitors have shown potential therapeutic effects in skeletal muscle-related disorders on osteoporosis, IVDD, OA, and other musculoskeletal diseases by improving bone and muscle homeostasis regulation, inhibiting ECM degradation, and reducing inflammation. This evidence concerns the gene STING1 and musculoskeletal system disorder.